Digital health start-up VitalSignum is on track to launch Beat2Phone, a small mobile device that detects arrhythmia by measuring the patient’s ECG, with the first production batch due to be on the market early next month.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.